Goldman Sachs
Showing 151–165 of 533 transcripts.
- 35 min
‘The Technology Opportunity of Our Lifetimes’: Bessemer's Byron Deeter
Goldman Sachs co-chairman Ken Hirsch interviews Bessemer Venture Partners partner Byron Dieter regarding the firm's "empowerment" investment strategy and its aggressive $10 billion allocation toward AI infrastructure and application sectors. Dieter emphasizes prioritizing elite founding teams over ideas while leveraging a platform of 150+ IPOs to syndicate risk, a shift driven by the predicted expansion of Total Addressable Markets from infrastructure to "answer engine" outcomes. The discussion further highlights Bessemer's evolution into a full-service operational support model, exemplified by founder well-being initiatives like STRIVE and a strategic focus on avoiding "crimes of omission" in high-growth markets.
- 11 min
The Bubble Question
Following a trade war-induced volatility spike that triggered a brief S&P 500 drawdown, market resilience was demonstrated by record retail options activity and strong third-quarter earnings from major U.S. banks and luxury firms. Analysts reject systemic bubble narratives, noting that current valuations are supported by genuine earnings growth and projected $520 billion in retail net demand through 2026 rather than irrational expansion. While a modest 5–8% correction is considered plausible before the year-end, the market is underpinned by robust corporate buybacks and upcoming fiscal stimulus expected to sustain consumer spending.
- 19 min
The Rise of Secondaries: Unlocking Liquidity in Private Markets
Harold Hope, Alex Blostein, Allison Nathan
The global secondary private markets reached $650 billion in assets under management with a 15% annual growth rate, driven by $200 billion in projected transaction volumes and shifting demand for liquidity among institutional and retail investors. Market dynamics now favor a 50-50 split between LP-led and GP-led continuation vehicles, as general partners across the top 200 managers increasingly utilize these structures to retain trophy assets and mitigate vintage risk. While a $200 billion supply of dry powder currently creates a favorable supply-demand imbalance, the sector is evolving from a tactical tool to a core allocation strategy expected to accelerate further as turnover rates mature over the next decade.
- 8 min
Can the Rally Continue?
Ashok Varadhan maintains a constructive outlook on U.S. equities, projecting a policy interest rate normalization near 3% within the year and a market consolidation in the fourth quarter before a 2026 resumption. While advising investors to remain long and hedge downside risks through cheaply priced puts during a low-volatility environment, he identifies a structural shift away from fiat currencies into assets like Bitcoin and AI-driven stocks as a response to fiscal expansion. This strategy navigates potential Q4 risks from a government shutdown that delays critical economic data, ensuring the portfolio capitalizes on the enduring technological investment cycle while accounting for tariff absorption and crowded consensus positions.
- 18 min
The Future of Software Engineering: Cognition’s Russell Kaplan
Cognition, founded by former Olympiad medalists and now valued at $4 billion, is advancing software engineering by deploying Devin, an autonomous AI agent capable of executing end-to-end development tasks. The company differentiates itself through a dual-product strategy combining Devin for independent execution with the recently acquired Windsurf IDE for human-in-the-loop collaboration, targeting enterprise integration into proprietary codebases. While AI capabilities in coding are projected to double every seven months, Cognition aims to elevate Devin to senior engineer status within a year, though future growth is anticipated to be constrained by energy availability rather than data scarcity.
- 21 min
The Shutdown’s Economic Impact
A partisan role reversal has precipitated a broad federal government shutdown as Democrats withhold support for clean spending bills to demand the extension of ACA health insurance subsidies, a move that polling suggests is driving voter blame toward Republicans. The crisis faces a critical resolution pressure point on October 15 when active-duty military personnel miss a pay cycle, a deadline that historically compels congressional action to avoid widespread economic disruption. While the shutdown projects to reduce Q4 GDP by approximately 0.3 percentage points and delay key economic data releases, market analysts and the Federal Reserve anticipate the stalemate will resolve quickly through a targeted fiscal compromise.
- 44 min
Memorial Sloan Kettering Cancer Center’s CEO on the Future of Cancer Treatment
Selwyn M. Vickers, Brian Robinson, Dr. Selwyn Vickers
Memorial Sloan Kettering leverages its vast biobank and dual expertise in computational oncology to drive a "golden era" of cancer treatment, where AI-driven predictive models and breakthroughs in immunotherapy have transformed survival rates for aggressive malignancies. Concurrently, the institution confronts rising youth cancer incidence and systemic health inequities by developing accessible genetic screening tools and deploying low-infrastructure immunotherapy protocols globally. These clinical and technological advances are grounded in a leadership philosophy that prioritizes professional excellence to dismantle socioeconomic barriers and improve care access for underserved populations.
- 9 min
Hidden Volatility
Despite a S&P 500 rally driven by retail call-option activity that has inverted standard volatility skew, market strategists are utilizing inverted skew arbitrage and protective put strategies to navigate heightened single-stock risks amid potential government shutdown impacts. Although the October "boogeyman" is historically muted outside of major crises, the concentration of mega-cap tech names and upcoming AI catalysts are expected to be the primary drivers of volatility. With immediate shutdown concerns already factored into a modest market gain, attention is shifting toward Federal Reserve minutes and the delayed Non-Farm Payrolls report to guide the near-term economic outlook.
- 19 min
AI Exchanges: The Role of Data
Neema Raphael, George Lee, Allison Nathan
Nima Raphael, a 20-year Goldman Sachs veteran, details the industry's strategic shift from deterministic coding to probabilistic machine learning, emphasizing the critical role of proprietary enterprise data in driving innovation beyond consumer hype. He argues that future AI differentiation relies on overcoming public data saturation by leveraging trapped internal datasets through rigorous engineering and emerging agent-based automation. Raphael further warns that sustained value depends on distinguishing high-quality insights from synthetic data risks while preparing for new frontiers in video and robotics generation.
- 23 min
Will macro fuel more stock gains?
Analysts project the Federal Reserve will implement two additional rate cuts by year-end to address labor market risks, targeting a terminal rate near 3% as the economy navigates mixed employment signals and structural uncertainties. This easing cycle, expected to conclude by December 2026, aims to support risk assets and sustain growth while keeping inflation pressures contained amid a bearish outlook for oil and tariff impacts. Despite valuation concerns and skepticism regarding AI capital expenditure sustainability, the prevailing view suggests that resilient fundamentals and policy shifts will maintain upside momentum for the broader market through 2026.
- 10 min
A Contrarian Call on Europe
Despite a historic six-month equity rally, professional investors maintain a constructive stance with deployed capital levels indicating the market remains unsretched. The event highlights a divergence where European value stocks and small caps outperform US large-cap growth, while specific opportunities arise in Chinese AI and German domestic beneficiaries driven by defense spending. Participants further examine strategies to capitalize on compressed index volatility and persistent single-stock dispersion amidst upcoming inflation data and month-end rebalancing pressures.
- 26 min
How Reliable is Economic Data?
Erica Groshen, Arthur Laffer, Alberto Cavallo, Joseph Briggs, Allison Nathan
Recent concerns regarding the reliability of U.S. economic data stem from funding cuts, a 15–20% staffing reduction at the Bureau of Labor Statistics, and the dismissal of its Commissioner by President Trump. Goldman Sachs research indicates that these operational constraints and declining survey responsiveness are increasing standard errors in key indicators like the CPI and JOLTS, creating a risk of data divergence. While current safeguards and institutional checks may prevent a total collapse of credibility, analysts warn that prolonged political interference and resource depletion could eventually erode market trust to the extent seen in Argentina.
- 10 min
Will Fed Cuts Drive Stocks Higher?
Tony Pasquariello, Chris Hussey
The Federal Reserve signaled a trajectory of five rate cuts over the next few years while revising upward its growth and inflation expectations, a move Goldman Sachs views as consistent with its internal forecasts despite minor timing differences. Investment strategists advocate for a continued focus on US big-cap technology and Japan due to strong earnings momentum and shareholder reforms, while remaining cautious about European markets and potential valuation compression in the US. Market participants will closely monitor upcoming employment data and the evolving US labor landscape as volatility is expected to rise following the October earnings reporting season.
- 30 min
The Healthcare Outlook: Macro Challenges and Biotech Innovations
Asad Haider, Amit Sinha, Allison Nathan
Following five years of underperformance driven by capital rotation into artificial intelligence and regulatory uncertainty regarding drug pricing, the U.S. healthcare sector is undergoing a structural correction characterized by a declining S&P 500 weighting and a shift in early-stage capital formation toward private markets. Despite these macro headwinds, specific innovation cycles in oral obesity treatments, oncology, and cardiovascular therapeutics are creating idiosyncratic opportunities, particularly within the mid-cap biotech space where investors are beginning to recognize potential for outsized returns on revenue. While large pharmaceutical firms report initial AI-driven cost savings, market participants remain cautious, awaiting tangible earnings improvements before fully re-rating assets in an environment defined by a looming patent cliff and reduced federal research funding.
- 38 min
Inside the Olympics: Resilience and the Road to LA 2028
David Solomon, Chuck Aoki, Meghan Duggan, Gene Sykes, Nick
The U.S. Olympic & Paralympic Committee highlighted the contrasting yet complementary journeys of Paralympian Chuck Aoki and Olympian Megan Dugan to illustrate the movement's reliance on mental fortitude, community, and a legacy of inspiration. Detailed accounts of their competitive strategies, including the 2018 women's hockey team's visualization tactics and Aoki's resilience against disability, underscore the non-commercial, social enterprise nature of the Olympic and Paralympic movements. Looking toward the future, USOPC Chair Gene Sykes and new CEO Reynolds Hoover are leveraging military-grade planning to orchestrate the record-breaking Los Angeles 2028 Games, aiming to unify diverse global populations while minimizing strain on local infrastructure.